ArticleClinics and research in hepatology and gastroenterology2021

The type of KRAS mutation drives PI3Kα/γ signalling dependency: Implication for the choice of targeted therapy in pancreatic adenocarcinoma patients.

Coralie Cayron et al.PubMed ↗Publisher ↗

No numbers read from the abstract.